Labcorp Holdings Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Labcorp Holdings Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $44 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 85% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 22% of its market value (net debt). Lower than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$223Over the last 3 years, every $100 of reported profit came with $223 of operating cash.
Higher than 82% of Healthcare companies in United States.
Self-Funding Ratio
3.3×Over the last 3 years its own operating cash covered its investment spending (capex) 3.3 times.
Higher than 80% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $13 tied up three years earlier.
Less money tied up than 74% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
−$19Sales grew 18% in 3 years, but profit fell: $19 less profit per $100 of extra sales.
Lower than 76% of Healthcare companies in United States.
Asset Productivity Ratio
+18% / -9%In 3 years sales changed by +18% while total assets changed by -9%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
3.3×Debt due within a year is covered 3.3 times by its yearly operating cash.
Higher than 77% of Healthcare companies in United States.
Cash Cushion Ratio
−22%Debt, after subtracting cash, equals 22% of its market value (net debt).
Lower than 85% of Healthcare companies in United States.
Tangible Assets Ratio
44%Of every $100 the company owns, $44 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 85% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 79% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Labcorp Holdings Inc. owes $0.53 for every $1 it owns. Net profit rose 17% in the year to Dec 2025, and shrank 12% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
27.3Investors pay $27.3 for every $1 of Labcorp Holdings Inc.'s yearly profit, higher than 50% of Healthcare companies in United States.
P/B ratio
3.11The share price is 3.11 times Labcorp Holdings Inc.'s book value per share, higher than 57% of Healthcare companies in United States.
Market cap
$26.8 BThe total market value of all of Labcorp Holdings Inc.'s shares at today's price (share price × number of shares), larger than 94% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$8.6 BWhat Labcorp Holdings Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$106.13Net worth divided by the number of shares. The share price of $329.93 is 3.1 times this, which is the P/B above.
Return on equity (ROE)
11.7%Labcorp Holdings Inc. earned 11.7% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
Owes vs Owns
0.53×Labcorp Holdings Inc. owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Dividend yield
0.89%Labcorp Holdings Inc. pays 0.89% of its share price as dividends a year, lower than 57% of dividend-paying Healthcare companies in United States.
Revenue growth
+7%Revenue rose 7% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
+17%Net profit rose 17% in the year to Dec 2025, and shrank 12% a year on average over 3 years.
Profit margin
6.3%Labcorp Holdings Inc. keeps $6 of every $100 of revenue as net profit.
Cash quality
1.9×Cash from Labcorp Holdings Inc.'s business was 1.9× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
6.8×Labcorp Holdings Inc.'s operating profit covered its interest costs 6.8 times in the year to Dec 2025.
Cash vs debt
Net debtLabcorp Holdings Inc. had $6.0 B more debt than cash (net debt) at Dec 2025.
Questions
What is Labcorp Holdings Inc.'s P/E ratio?
Investors pay $27.3 for every $1 of Labcorp Holdings Inc.'s yearly profit, higher than 50% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Labcorp Holdings Inc.: $26.8 B ÷ $8.6 B (30 Jun 2026) = 3.1.
What is Labcorp Holdings Inc.'s return on equity?
Labcorp Holdings Inc. earned 11.7% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
How much does Labcorp Holdings Inc. owe compared with what it owns?
Labcorp Holdings Inc. owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Does Labcorp Holdings Inc. pay a dividend?
Yes. Labcorp Holdings Inc. pays 0.89% of its share price as dividends a year, lower than 57% of dividend-paying Healthcare companies in United States.
Is Labcorp Holdings Inc.'s revenue growing?
Revenue rose 7% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.